R Hullmann
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Adverse Reactions
Papers in
-
- Antibiotic Use and Resistance 1
-
- Renal Transplantation Outcomes and Treatments 1
- Co-authors
- P. SchachtG. ArcieriH. SchmidtB HampelRoger EcholsEric C. GriffithBarbara O’BrienAidan Westwood
- Journals
- Infection (3 papers)The American Journal of Medicine (1 paper)The Pediatric Infectious Disease Journal (1 paper)PubMed (5 papers)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
R Hullmann
8 papers receiving 373 citations
Peers
Comparison fields: 5 of 68
- Molecular Medicine 79
- Pharmacology 243
- Applied Microbiology and Biotechnology 10
- Epidemiology 159
- Clinical Biochemistry 28
Countries citing papers authored by R Hullmann
This map shows the geographic impact of R Hullmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Hullmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Hullmann more than expected).
Fields of papers citing papers by R Hullmann
This network shows the impact of papers produced by R Hullmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Hullmann. The network helps show where R Hullmann may publish in the future.
Co-authors
The 13 scholars most cited alongside R Hullmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 126 | |
| 2 | 1991 | 118 | |
| 3 | 1989 | 72 | |
| 4 | 1988 | 73 | |
| 5 | 1988 | 12 | |
| 6 | [Clinical results with azlocillin (author's transl)]. | 1979 | 2 |
| 7 | [Therapy with an antibiotic combination mezlocillin/oxacillin and clinical experience/First communication: Adults (author's transl)]. | 1979 | 0 |
| 8 | [Clinical results with mezlocillin (author's transl)]. | 1979 | 1 |
| 9 | [Propiramfumarate in a clinical study]. | 1974 | 2 |
| 10 | [Blood circulation and ECG under the effect of propiramfumarate. Results of a double blind study]. | 1974 | 1 |
About R Hullmann
R Hullmann is a scholar working on Applied Microbiology and Biotechnology, Transplantation, Pharmacology, Pediatrics, Perinatology and Child Health and Molecular Medicine, having authored 10 papers that have together received 407 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Pharmaceutical studies and practices (2 papers), Cancer therapeutics and mechanisms (1 paper), Urinary Tract Infections Management (1 paper), Renal Transplantation Outcomes and Treatments (1 paper), Antifungal resistance and susceptibility (1 paper), Pharmacological Effects and Toxicity Studies (1 paper) and Antibiotic Use and Resistance (1 paper). The work is most often cited by research in Molecular Medicine (79 citations), Pharmacology (243 citations), Applied Microbiology and Biotechnology (10 citations), Epidemiology (159 citations) and Clinical Biochemistry (28 citations). R Hullmann has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include P. Schacht, G. Arcieri, H. Schmidt, B Hampel, Roger Echols, Eric C. Griffith, Barbara O’Brien, Aidan Westwood, Hendrik Van Poppel and L. Baert. Their work appears in journals such as Infection, The American Journal of Medicine, The Pediatric Infectious Disease Journal and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.